These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 3905319)
41. Proceedings: Simultaneous study on mutagenic and carcinogenic effects of tetrazenes. Buselmaier W; Fleig J Mutat Res; 1975 Aug; 29(2):293-4. PubMed ID: 1186766 [No Abstract] [Full Text] [Related]
42. Application of a geometric parameter defining molecular shape, for the quantitation of interaction of polycyclic aromatic hydrocarbons with enzyme systems. Lamparczyk H; Radecki A; Kaliszan R Biochem Pharmacol; 1981 Aug; 30(16):2337-41. PubMed ID: 7295344 [No Abstract] [Full Text] [Related]
43. Mutagenicity of ethyleneimine. Verschaeve L; Kirsch-Volders M Mutat Res; 1990 Jan; 238(1):39-55. PubMed ID: 2406584 [No Abstract] [Full Text] [Related]
44. Mutagens as carcinogens: development of current concepts. Lawley PD Mutat Res; 1989 Jul; 213(1):3-25. PubMed ID: 2664491 [TBL] [Abstract][Full Text] [Related]
45. Chemical reactivity, biotransformation, and toxicity of polychlorinated aliphatic compounds. Bonse G; Henschler D CRC Crit Rev Toxicol; 1976 Oct; 4(4):395-409. PubMed ID: 791581 [No Abstract] [Full Text] [Related]
46. Electrophilic sulfuric acid ester metabolites as ultimate carcinogens. Miller JA; Miller EC Adv Exp Med Biol; 1986; 197():583-95. PubMed ID: 3766283 [No Abstract] [Full Text] [Related]
47. The binding of ortho-aminoazotoluene in proliferating tissues. Lawson TA; Dzhioev FK Chem Biol Interact; 1970 Oct; 2(3):165-74. PubMed ID: 5524162 [No Abstract] [Full Text] [Related]
48. The chemical and biochemical reactivity of dichlorvos. Wright AS; Hutson DH; Wooder MF Arch Toxicol; 1979 Apr; 42(1):1-18. PubMed ID: 378182 [TBL] [Abstract][Full Text] [Related]
49. Alteration of microsomal and mitochondrial sites of metabolic control during chemical carcinogenesis. ARCOS JC Bull Tulane Univ Med Fac; 1961 May; 20():133-50. PubMed ID: 13684058 [No Abstract] [Full Text] [Related]
50. Chemistry and biological activity of N 1 -acyl-4-arylazopyrazoles. Garg HG; Arora V J Pharm Sci; 1972 Jan; 61(1):130-2. PubMed ID: 5058632 [No Abstract] [Full Text] [Related]
51. The prospects for a simplified and internationally harmonized approach to the detection of possible human carcinogens and mutagens. Gatehouse DG; Tweats DJ Mutagenesis; 1986 Sep; 1(5):307-8. PubMed ID: 3331671 [No Abstract] [Full Text] [Related]
52. Mutagenicity of Maillard browning products obtained from a starch--glycine model system. Wei CI; Kitamura K; Shibamoto T Food Cosmet Toxicol; 1981 Dec; 19(6):749-51. PubMed ID: 7327476 [No Abstract] [Full Text] [Related]
53. Mutagenicity in yeast of nitroquinolines and related compounds. Epstein SS; Pierre JA Toxicol Appl Pharmacol; 1969 Sep; 15(2):451-60. PubMed ID: 5804756 [No Abstract] [Full Text] [Related]
54. Proceedings: The kinetic response of HeLa cells to MAM acetate treatment. Bedford AJ; Knowles JD; Kenny TE; Van den Berg HW Br J Cancer; 1974 Jan; 29(1):93. PubMed ID: 4820954 [No Abstract] [Full Text] [Related]
55. In vitro studies on the biotransformation of metanil yellow. Srivastava LP; Khanna SK; Singh GB; Murti CR Environ Res; 1982 Feb; 27(1):185-9. PubMed ID: 7067676 [No Abstract] [Full Text] [Related]